Cy5.5 NHS Ester: Near-Infrared Fluorescent Dye for Biomolecule Labeling

Introduction: Principle and Setup of Cy5.5 NHS Ester Labeling

Cy5.5 NHS ester (non-sulfonated) stands at the forefront of near-infrared fluorescent dye for biomolecule labeling, enabling highly sensitive detection and imaging of proteins, peptides, and nucleic acids. Its unique photophysical profile—excitation at 684 nm and emission at 710 nm—delivers deep-tissue penetration and low background, ideal for in vivo fluorescence imaging and optical imaging of tumors. The NHS ester group ensures selective covalent attachment to primary amines, forming stable amide bonds on biomolecules. As a result, Cy5.5 NHS ester is the dye of choice for researchers seeking high signal-to-noise ratios in fluorescent labeling in molecular biology, protein and peptide labeling, and optical imaging of subcutaneous tumors.

Notably, the Cy5.5 NHS ester (non-sulfonated) offered by APExBIO delivers a high extinction coefficient of 209,000 M⁻¹cm⁻¹ and a quantum yield of 0.2. Its solubility profile (≥35.82 mg/mL in DMSO) and non-sulfonated structure facilitate broad compatibility across labeling protocols, especially where hydrophobicity or membrane permeability are advantageous. These properties make it not only a powerful protein labeling fluorescent dye but also a preferred fluorescent probe for biomedical research, including tumor xenograft imaging and neuromodulation studies.

Step-by-Step Experimental Workflow and Protocol Enhancements

1. Reagent Preparation: Maximizing Solubility and Stability

• Dissolution: Due to low aqueous solubility, dissolve Cy5.5 NHS ester in anhydrous DMSO or DMF to prepare a concentrated stock solution (e.g., 10 mM). Use freshly opened vials and minimize exposure to moisture and light.
• Aliquoting: Prepare single-use aliquots to avoid repeated freeze-thaw cycles. Store solid dye at -20°C in the dark for up to 24 months; prepared solutions should be used immediately and not stored long-term.

2. Labeling Biomolecules: Protocol for High-Efficiency Conjugation

1. Buffer Selection: Use amine-free buffers (e.g., PBS, pH 7.2–8.0, without Tris or glycine). Tris and other primary amine-containing buffers will compete with your target biomolecule for dye conjugation.
2. Reaction Setup: Add the Cy5.5 NHS ester stock to your biomolecule solution (proteins, peptides, or oligonucleotides), ensuring the final DMSO concentration does not exceed 10% v/v to avoid denaturation.
3. Molar Ratio Optimization: A typical labeling ratio is 3–10 molar equivalents of dye per mol of protein, adjusted based on the number of accessible lysines or N-terminal amines.
4. Reaction Conditions: Incubate at room temperature (20–25°C) for 30–60 minutes, protected from light. For oligonucleotides, mild agitation can enhance uniform labeling.
5. Purification: Remove free dye using desalting columns, size-exclusion chromatography, or spin filters (10 kDa MWCO for proteins). Check the degree of labeling spectroscopically using the dye's extinction coefficient (209,000 M⁻¹cm⁻¹ at 684 nm).

For detailed protocol enhancements and scenario-driven guidance, the article "Best Practices in Near-Infrared Biomolecule Labeling with Cy5.5 NHS Ester" offers evidence-based strategies to maximize reproducibility and sensitivity, complementing this workflow with troubleshooting for cell-based assays.

Advanced Applications and Comparative Advantages

1. Optical Imaging of Tumors and In Vivo Fluorescence Imaging

The superior tissue penetration and minimal autofluorescence in the near-infrared (NIR) spectrum make Cy5.5 NHS ester a benchmark tumor imaging agent and in vivo tumor imaging dye. Its high extinction coefficient and moderate quantum yield facilitate robust signal detection even in deep tissues. In "Cy5.5 NHS Ester: Advanced Near-Infrared Fluorescent Dye for In Vivo Imaging", researchers highlight its use in tracking tumor growth, therapeutic response, and nanoparticle biodistribution in live animal models.

Moreover, the dye's low background interference and high specificity for amino group labeling make it ideal for optical imaging of biomolecules, enabling multiplexed detection and quantification in complex tissues. Its application extends to fluorescent labeling for flow cytometry, fluorescent dye for western blot, and advanced cell imaging, where high sensitivity and photostability are paramount.

2. Integration with Nanoplatforms for Neuromodulation and Drug Delivery

Recent advances, such as the work by Li et al. in "Ultrasound-Triggered Biomimetic Piezo-Nanoplatforms for Non-Invasive Epilepsy Treatment", underscore the value of NIR dyes like Cy5.5 NHS ester in tracking and evaluating functional nanomaterials in vivo. In this study, fluorescent labeling enabled real-time visualization of nanoplatform biodistribution and targeting efficacy, accelerating experimental validation and translation. The dye's compatibility with piezoelectric and biomimetic nanoparticles exemplifies its utility as a fluorescent probe for molecular biology and neuromodulation research.

3. Comparative Advantages over Other NHS Ester Dyes

• Deeper Tissue Penetration: Compared to Cy3 or Cy5 variants, Cy5.5 NHS ester offers superior imaging depth due to its longer excitation/emission wavelengths (684/710 nm), reducing tissue autofluorescence and scattering.
• Optimized Hydrophobicity: The non-sulfonated structure enhances membrane permeability and lipophilic interactions, which can be advantageous in certain live-cell and in vivo applications.
• Versatile Biomolecule Compatibility: It labels proteins, peptides, and nucleic acids with high efficiency, making it a go-to oligonucleotide labeling dye and plasmid DNA labeling reagent for diverse experimental needs.

For a detailed comparison with other NHS ester dyes and integration into translational research, see "Advancing Tumor Imaging and Microbiome-Targeted Therapies", which extends the use-case landscape to immuno-oncology and nanovaccine development.

Troubleshooting and Optimization Tips

Common Challenges and Solutions

• Poor Dye Solubility: Always dissolve in anhydrous DMSO or DMF. Do not attempt to dissolve directly in aqueous buffer. If precipitation occurs during labeling, reduce dye concentration or increase organic co-solvent to ≤10% v/v.
• Low Labeling Efficiency: Confirm that buffers are amine-free and pH is within 7.2–8.0. Increase dye molar ratio incrementally. For proteins with few lysines, consider gentle denaturation (e.g., 1 M urea) to expose more reactive amines.
• High Background Signal: Inadequate removal of unreacted dye is a frequent culprit. Employ size-exclusion chromatography or at least three buffer exchanges with spin columns. Validate removal spectroscopically before proceeding to imaging.
• Loss of Fluorescence: Avoid prolonged light exposure and repeated freeze-thaw cycles. Prepare dye solutions fresh and protect from ambient light at all times.
• Protein Aggregation or Precipitation: Limit DMSO content to ≤10% v/v and optimize buffer ionic strength. If aggregation persists, test different buffer systems or include gentle detergents (e.g., 0.01% Tween-20) if compatible with downstream assays.

For troubleshooting in the context of cell-based functional assays, "Reliable Cell Assays and Tumor Imaging with Cy5.5 NHS Ester" offers complementary advice and protocol refinements tailored to cell viability, proliferation, and cytotoxicity workflows.

Quantitative Assessment and Data Interpretation

• Degree of Labeling (DOL): Calculate using absorbance at 684 nm (dye) and 280 nm (protein). For Cy5.5 NHS ester, use the extinction coefficient (209,000 M⁻¹cm⁻¹) for precise quantification.
• Spectral Overlap: When multiplexing, ensure that emission profiles of co-labeled dyes do not overlap significantly with Cy5.5 (emission 710 nm), minimizing bleed-through in detection channels.

Future Outlook: Expanding the Frontier of Near-Infrared Labeling

As the demand for multiplexed, high-sensitivity, and deep-tissue imaging grows, Cy5.5 NHS ester (non-sulfonated) is poised to remain a cornerstone amino group reactive fluorescent dye in biomedical research. Innovations such as real-time in vivo tracking of nanoplatforms—as demonstrated in the Li et al. epilepsy neuromodulation study—underscore the dye’s translational impact from bench to preclinical validation.

Emerging applications include integration into smart drug delivery systems, biosensors, and high-throughput screening platforms leveraging near-infrared fluorescence imaging. Cross-disciplinary strategies, such as combining NIR fluorophores with piezoelectric or biomimetic nanomaterials, will further expand the utility of Cy5.5 NHS ester for next-generation diagnostics and therapies.

For a comprehensive review of best practices and application scenarios, consult "Cy5.5 NHS Ester (Non-Sulfonated): Near-Infrared Dye for Robust In Vivo Imaging". This resource contrasts Cy5.5 with other NIR dyes and discusses experimental pitfalls and solutions.

Conclusion

The Cy5.5 NHS ester (non-sulfonated) from APExBIO empowers translational scientists to achieve exceptional sensitivity, photostability, and specificity in fluorescent labeling of proteins, peptides, and oligonucleotides. Its proven track record in advanced in vivo tumor imaging, neuromodulation, and molecular diagnostics is backed by a robust evidence base and supported by a growing portfolio of protocol-driven resources. By adopting best practices and leveraging this high extinction coefficient dye, researchers can overcome common labeling challenges and drive innovation in biomedical discovery.